FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) with AI Score 47/100 (Weak). FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) aims to replicate the performance of the MSCI USA IMI Health Care Index. The fund provides exposure to a broad range of U. S. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 17, 2026FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) Financial Services Profile
FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) offers investors targeted exposure to the U.S. healthcare sector through a diversified index-tracking approach. With a focus on mirroring the MSCI USA IMI Health Care Index, FHLC provides a cost-effective way to access a wide range of healthcare companies, appealing to those seeking sector-specific growth within their portfolios.
Investment Thesis
FHLC presents a compelling investment vehicle for those seeking targeted exposure to the U.S. healthcare sector. As an index-tracking ETF, FHLC offers diversification across a wide range of healthcare companies, mitigating company-specific risk. The healthcare sector is expected to experience continued growth due to factors such as an aging population, advancements in medical technology, and increasing healthcare spending. FHLC's passive investment strategy aims to replicate the performance of the MSCI USA IMI Health Care Index, providing investors with a cost-effective way to participate in this growth. With a beta of 0.73, FHLC exhibits lower volatility compared to the broader market, potentially offering a more stable investment option. The absence of dividend yield may be a drawback for income-seeking investors, but the potential for capital appreciation in the healthcare sector remains a key driver of investment in FHLC.
Based on FMP financials and quantitative analysis
Key Highlights
- FHLC tracks the MSCI USA IMI Health Care Index, providing broad exposure to the U.S. healthcare sector.
- The ETF has a market capitalization of $3.02 billion, indicating substantial investor interest.
- FHLC's beta of 0.73 suggests lower volatility compared to the overall market.
- The ETF does not offer a dividend yield, focusing on capital appreciation.
- FHLC's performance is directly linked to the performance of the underlying MSCI USA IMI Health Care Index.
Competitors & Peers
Strengths
- Broad exposure to the U.S. healthcare sector.
- Cost-effective index-tracking approach.
- Diversification across a wide range of healthcare companies.
- Managed by Fidelity, a well-established asset management firm.
Weaknesses
- No dividend yield.
- Performance is directly tied to the performance of the MSCI USA IMI Health Care Index.
- Subject to sector-specific risks.
- Passive investment strategy may not outperform actively managed funds.
Catalysts
- Ongoing: Aging population driving increased demand for healthcare services.
- Ongoing: Technological advancements and innovation in healthcare.
- Ongoing: Increasing healthcare spending in developed and developing countries.
- Upcoming: Potential for new drug approvals and medical breakthroughs.
Risks
- Potential: Changes in government regulations and healthcare policies.
- Potential: Increased competition from other healthcare ETFs and mutual funds.
- Potential: Economic downturns that could reduce healthcare spending.
- Potential: Unexpected events that could negatively impact the healthcare sector.
- Ongoing: Sector-specific risks associated with the healthcare industry.
Growth Opportunities
- Aging Population: The global population is aging, leading to increased demand for healthcare services and products. This demographic shift is expected to drive growth in the healthcare sector, benefiting companies held within FHLC. As the number of older adults increases, the demand for pharmaceuticals, medical devices, and healthcare services will likely rise, creating opportunities for companies in the index. This trend is expected to continue over the next decade, providing a long-term growth catalyst for FHLC.
- Technological Advancements: Innovation in healthcare technology, such as telemedicine, artificial intelligence, and gene editing, is transforming the industry. Companies that are at the forefront of these advancements are likely to experience significant growth, contributing to the overall performance of FHLC. The integration of technology into healthcare is expected to improve efficiency, reduce costs, and enhance patient outcomes. This trend is projected to accelerate in the coming years, creating new opportunities for companies in the healthcare sector.
- Increased Healthcare Spending: Healthcare spending is projected to continue to rise in developed and developing countries. This increase is driven by factors such as an aging population, chronic diseases, and advancements in medical treatments. As healthcare spending increases, companies in the healthcare sector are likely to benefit, leading to potential growth for FHLC. Government policies and regulations also play a significant role in shaping healthcare spending patterns, creating both opportunities and challenges for companies in the sector.
- Expansion into Emerging Markets: Many healthcare companies are expanding their operations into emerging markets, where there is a growing demand for healthcare services and products. This expansion can lead to increased revenue and profitability for these companies, contributing to the overall performance of FHLC. Emerging markets offer significant growth potential due to their large populations and increasing disposable incomes. However, companies operating in these markets also face challenges such as regulatory hurdles and cultural differences.
- Mergers and Acquisitions: The healthcare industry is characterized by ongoing mergers and acquisitions, as companies seek to expand their product portfolios, gain access to new markets, and achieve economies of scale. These transactions can create value for shareholders and contribute to the overall performance of FHLC. Mergers and acquisitions can also lead to increased competition and innovation within the healthcare sector, benefiting consumers and investors alike. The pace of mergers and acquisitions in the healthcare industry is expected to remain strong in the coming years.
Opportunities
- Growth in the healthcare sector driven by an aging population.
- Advancements in medical technology.
- Increased healthcare spending.
- Expansion into emerging markets.
Threats
- Changes in government regulations and healthcare policies.
- Increased competition from other healthcare ETFs and mutual funds.
- Economic downturns that could reduce healthcare spending.
- Unexpected events that could negatively impact the healthcare sector.
Competitive Advantages
- Index-tracking: FHLC's index-tracking approach provides a cost-effective way to access the healthcare market.
- Diversification: The ETF offers diversification across a wide range of healthcare companies, reducing risk.
- Low expense ratio: FHLC's expense ratio is competitive, making it a noteworthy option for cost-conscious investors.
About FHLC
The FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) is designed to provide investment results that correspond generally to the performance of the MSCI USA IMI Health Care Index. This index represents a broad range of companies in the U.S. healthcare sector, encompassing pharmaceuticals, biotechnology, healthcare equipment, healthcare providers, and services. FHLC offers investors a convenient and cost-effective way to gain exposure to the entire healthcare sector, rather than selecting individual stocks. The ETF operates on a passive investment strategy, aiming to replicate the index's composition and weighting as closely as possible. This approach allows investors to participate in the overall growth and performance of the U.S. healthcare market. By holding a diversified portfolio of healthcare stocks, FHLC seeks to minimize company-specific risk while capturing the potential upside of the sector. The fund is managed by Fidelity, a well-established asset management firm with extensive experience in managing index-tracking ETFs. FHLC is suitable for investors who have a positive outlook on the healthcare sector and are seeking a simple and efficient way to allocate capital to this area of the market. The ETF's expense ratio is designed to be competitive, making it a noteworthy option for cost-conscious investors. FHLC's performance is directly tied to the performance of the MSCI USA IMI Health Care Index, so investors may want to evaluate the index's composition and historical performance when evaluating the ETF.
What They Do
- Tracks the performance of the MSCI USA IMI Health Care Index.
- Provides exposure to a broad range of U.S. healthcare companies.
- Offers a cost-effective way to invest in the healthcare sector.
- Replicates the index's composition and weighting.
- Minimizes company-specific risk through diversification.
- Allows investors to participate in the growth of the U.S. healthcare market.
- Offers a passive investment strategy.
Business Model
- FHLC generates revenue through management fees charged to investors.
- The fund's expense ratio covers the costs of managing and administering the ETF.
- Fidelity, the fund's manager, earns a percentage of the fund's assets under management (AUM).
Industry Context
FHLC operates within the asset management industry, specifically focusing on providing exposure to the healthcare sector. The healthcare industry is characterized by consistent growth driven by demographic trends and technological advancements. The competitive landscape includes other healthcare ETFs and mutual funds, each with varying investment strategies and expense ratios. FHLC's index-tracking approach offers a cost-effective way to access the healthcare market, appealing to investors seeking broad diversification. The ETF's success depends on the continued growth and innovation within the healthcare sector, as well as its ability to accurately replicate the performance of the MSCI USA IMI Health Care Index.
Key Customers
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for a cost-effective way to diversify their portfolios.
- Financial advisors who recommend FHLC to their clients.
- Retirement savers who want to allocate a portion of their assets to healthcare.
Financials
Chart & Info
FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) stock price: Price data unavailable
Latest News
-
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) Short Interest Up 126.7% in February
defenseworld.net · Mar 14, 2026
-
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
zacks.com · Mar 10, 2026
-
10 Fidelity ETFs With The Lowest Expense Ratio For Retirees
Yahoo! Finance: FHLC News · Jan 31, 2026
-
Is Fidelity's Health Care ETF A Good Buy Right Now?
247wallst.com · Jan 10, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FHLC.
Price Targets
Wall Street price target analysis for FHLC.
MoonshotScore
What does this score mean?
The MoonshotScore rates FHLC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) Short Interest Up 126.7% in February
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
10 Fidelity ETFs With The Lowest Expense Ratio For Retirees
Is Fidelity's Health Care ETF A Good Buy Right Now?
FIDELITY MSCI HEALTH CARE INDEX ETF Stock: Key Questions Answered
What does FIDELITY MSCI HEALTH CARE INDEX ETF do?
FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) is designed to mirror the performance of the MSCI USA IMI Health Care Index, providing investors with targeted exposure to the U.S. healthcare sector. The ETF achieves this by holding a diversified portfolio of stocks representing a broad range of companies within the healthcare industry, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. FHLC offers a cost-effective and convenient way for investors to participate in the growth of the healthcare sector without having to select individual stocks. The fund's passive investment strategy aims to replicate the index's composition and weighting as closely as possible, minimizing tracking error and providing investors with a return that closely matches the index's performance.
What do analysts say about FHLC stock?
AI analysis is pending for FHLC, so there is no current analyst consensus available. However, as an index-tracking ETF, FHLC's performance is closely tied to the performance of the MSCI USA IMI Health Care Index. Investors may want to evaluate the index's composition and historical performance when evaluating FHLC. Key valuation metrics for the healthcare sector, such as price-to-earnings ratios and growth rates, can provide insights into the potential future performance of FHLC. Growth considerations include the aging population, technological advancements in healthcare, and increasing healthcare spending. Investors should also be aware of the risks associated with the healthcare sector, such as regulatory changes and competition.
What are the main risks for FHLC?
As an ETF focused on the healthcare sector, FHLC is subject to sector-specific risks. Changes in government regulations and healthcare policies can significantly impact the profitability of healthcare companies held within the fund. Increased competition from other healthcare ETFs and mutual funds could lead to lower returns. Economic downturns could reduce healthcare spending, negatively impacting the performance of healthcare companies. Unexpected events, such as product recalls or lawsuits, could also negatively impact the healthcare sector. Investors should carefully consider these risks before investing in FHLC. Additionally, the fund's passive investment strategy may not outperform actively managed funds in certain market conditions.
What are the key factors to evaluate for FHLC?
FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) currently holds an AI score of 47/100, indicating low score. Key strength: Broad exposure to the U.S. healthcare sector.. Primary risk to monitor: Potential: Changes in government regulations and healthcare policies.. This is not financial advice.
How frequently does FHLC data refresh on this page?
FHLC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven FHLC's recent stock price performance?
Recent price movement in FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Broad exposure to the U.S. healthcare sector.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider FHLC overvalued or undervalued right now?
Determining whether FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying FHLC?
Before investing in FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending for FHLC, so some information may be incomplete.
- The information provided is based on available data and is subject to change.